AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022
Go back to AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022| Amgen Inc (NASDAQ: AMGN) | Delayed: 412.40 -5.44 (1.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $417.84 | 52 Week High | $176.85 | |||
| Open | $413.76 | 52 Week Low | $133.64 | |||
| Day High | $416.03 | P/E | 62.11 | |||
| Day Low | $410.50 | EPS | $6.64 | |||
| Volume | 442,400 | |||||

